Screener
Amneal Pharmaceuticals, Inc. AMRX Other operating expenses
Other operating expenses at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Acquisition costs | 7,600 | — | 12,753 | — |
| Restructuring and other charges | 554 | 1,024 | 1,204 | 1,595 |
| Charges (credit) related to legal matters, net | 8,057 | (390) | 8,751 | (390) |
| Other operating income | (1,298) | — | (8,239) | (5,122) |
| Operating income | 129,769 | 111,372 | 271,541 | 211,719 |
| Other (expense) income: | ||||
| Interest expense, net | (55,043) | (65,101) | (108,404) | (122,040) |
| Foreign exchange (loss) gain, net | (1,950) | 8,256 | (9,750) | 12,503 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s other operating expenses?
- Amneal Pharmaceuticals, Inc. (AMRX) reported other operating expenses of $1.3M in Q2 2026.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about Amneal Pharmaceuticals, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude